Helia Care has greatly increased its medical transaction network by joining forces with three of the biggest health systems in the U.S., which has added more than 100 hospitals to their network. The Helia Care solution starts working right away without needing any IT setup and usually saves over $1,000 per order. With this platform, healthcare providers can better control their spending and improve their relationships with suppliers across the supply chain.

Health Technology Insights: Collectly Launches Billie AI for Patient Eligibility and Benefits

Helia Care functions as a medical device transaction network that links providers, suppliers, and distributors through a SaaS platform. It replaces the old, slow, and costly bill-only process by using a digital agreement upfront to organize and align supplier and provider data. This method lowers hospital costs, speeds up payments for suppliers, and cuts down on unnecessary administrative tasks.

“Interest in our transaction platform has been growing a lot because it works quickly and is easy to use,” said Grant Siders, CEO of Helia Care. “Our network-based platform helps both providers and suppliers, making it very effective and attractive. The aim is to cut down on paperwork and make operations smoother so healthcare teams can focus on what really matters, taking care of patients.”

Health Technology Insights: Saama Launches AI TLF Analyzer to Revolutionize Clinical Reports

Siders continued, “Most major healthcare suppliers are now part of our network, and their contracts are fully connected with the provider’s purchasing process. Buying medical products should be simple, and with Helia Care, it’s just as easy as clicking a button, similar to ordering everyday items online.”

The company is working closely with health systems and suppliers across the country to bring a new way of doing healthcare procurement. So far, Helia Care has matched over 3,000 digital contracts, and the average hospital now has more than 85% of its suppliers on the network from the start. The company expects to keep growing and is investing in resources to support quick and effective implementations across the healthcare industry in the coming months.

Health Technology Insights: DESTINY-Lung06 Launches ENHERTU First-Line HER2+ NSCLC Trial

To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com